The overall goal of the Neuropathology Core (Core D) is to collect, characterize, store, and distribute well-characterized brains from autopsy participants from the Clinical Core, consisting of a group of well-documented individuals with Alzheimer disease (AD) and from normal control individuals without neurological disease. Specific Core D aims are: 1) diagnostic neuropathological evaluation of each brain, using a meticulous diagnostic approach, essential to all studies related to and stemming from these subjects. A standardardized approach for neuropathologic assessment is performed using published diagnostic criteria for those brains with recognizable neurodegenerative diseases. Neuropathological diagnosis of Alzheimer disease is based on NIA-Reagan Institute criteria. Other neurodegenerative diseases, coexistent with or instead of AD, will be evaluated by currently available published criteria. 2) Tissue preparation for research, collaboration. Processing and storing tissue from each brain and skeletal muscle sample collected will be performed for subsequent distribution to KU ADCC and other approved investigators to support AD-related research. Core D will contribute neuropathology case information to the NACC database. In order to assist investigators studying animal models of AD and related disorders, neuropathology services provided for study of human tissues will also be made available for animal-based researchers. Core D will also investigate new techniques and products for enhancing tissue preservation related to the proposed studies emphasized by this ADC. There is excellent integration with the other Cores, ranging from provision of tissue for genetic, metabolic studies (MGM Core), clinicopathological correlations (Clinical, Neuroimaging, Education Cores), centralization of data (Data Management Core), reviewing tissue requests (Administration Core), to community and resident education (Education Core). As new criteria for neuropathological assessments, new methodologies, and feedback from the other cores and the AD-neurodegenerative field occurs. Core D will show adaptability in order to implement change in assessments of the brains.
In studies of AD, it is important to correlate clinical and peripheral biospecimen data with brain pathological changes. These studies may contribute to biomarker development, additional insights into AD pathogenesis, and evaluation of response or adverse effects due to therapeutic interventions.
|Kim, Jieun; Choi, In-Young; Dong, Yafeng et al. (2015) Chronic fetal hypoxia affects axonal maturation in guinea pigs during development: A longitudinal diffusion tensor imaging and T2 mapping study. J Magn Reson Imaging 42:658-65|
|Vidoni, Eric D; Burns, Jeffrey M (2015) Exercise programmes for older people with dementia may have an effect on cognitive function and activities of daily living, but studies give inconsistent results. Evid Based Nurs 18:4|
|Selfridge, J Eva; Wilkins, Heather M; E, Lezi et al. (2015) Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure. J Bioenerg Biomembr 47:11-Jan|
|Gras, Laura Z; Kanaan, Saddam F; McDowd, Joan M et al. (2015) Balance and gait of adults with very mild Alzheimer disease. J Geriatr Phys Ther 38:7-Jan|
|Vangavaragu, Jhansi Rani; Valasani, Koteswara Rao; Fang, Du et al. (2014) Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics. J Alzheimers Dis 42:333-44|
|Harris, Janna L; Yeh, Hung-Wen; Swerdlow, Russell H et al. (2014) High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging. Neurobiol Aging 35:1686-94|
|Gan, Xueqi; Huang, Shengbin; Wu, Long et al. (2014) Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell. Biochim Biophys Acta 1842:220-31|
|Morris, Jill K; Honea, Robyn A; Vidoni, Eric D et al. (2014) Is Alzheimer's disease a systemic disease? Biochim Biophys Acta 1842:1340-9|
|Esteves, A Raquel; Swerdlow, Russell H; Cardoso, Sandra M (2014) LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis. Exp Neurol 261:206-16|
|Jiang, Lei; Bechtel, Misty D; Bean, Jennifer L et al. (2014) Effects of gangliosides on the activity of the plasma membrane Ca2+-ATPase. Biochim Biophys Acta 1838:1255-65|
Showing the most recent 10 out of 56 publications